tert-Butyl 4-amino-3-fluoropiperidine-1-carboxylate

Catalog No. :
ACAELF873
CAS No. :
934536-10-4
Molecular Formula :
C10H19FN2O2
Molecular Weight :
218.27

IUPAC Name:tert-butyl 4-amino-3-fluoropiperidine-1-carboxylate

tert-Butyl 4-amino-3-fluoropiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$64.00Login to see priceIn stockIn stock
5g95%$191.00Login to see priceIn stockIn stock
25g95%$750.00Login to see priceIn stockIn stock
100g95%$2525.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-amino-3-fluoropiperidine-1-carboxylate
IUPAC Nametert-butyl 4-amino-3-fluoropiperidine-1-carboxylate
MDL No.MFCD10566556
Molecular FormulaC10H19FN2O2
Molecular Weight218.27
SMILESFC1CN(C(OC(C)(C)C)=O)CCC1N
InChI KeyZQRYPCAUVKVMLZ-UHFFFAOYSA-N
SynonymPB31478 | 1-Boc-4-Amino-3-fluoropiperidine | 1-Boc-4-amino-3-fluoro-piperidine | MFCD10566556 | 4-AMINO-3-FLUORO-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | FT-0771186 | (3S,4S)-1-Boc-3-fluoropiperidin-4-amine | 1,8-dihydroxy-anthrone | SY099035 | HMS
CAS No.934536-10-4
PubChem CID21948952

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACAELF873 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXMFV741 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACAELF873 route product structure diagram
    ACAELF873934536-10-4 In Stock
Inquiry

2. ACAELF873 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAELF873 route product structure diagram
    ACAELF873934536-10-4 In Stock
Inquiry

Comments (0)